List of Tables
Table 1. Global Astragaloside III Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Astragaloside III Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Astragaloside III Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Astragaloside III Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Astragaloside III Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Astragaloside III Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
Table 7. Global Astragaloside III Sales by Region (2020-2025) & (kg)
Table 8. Global Astragaloside III Sales by Region (2026-2031) & (kg)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Astragaloside III Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
Table 11. Global Astragaloside III Production by Region (2020-2025) & (kg)
Table 12. Global Astragaloside III Production by Region (2026-2031) & (kg)
Table 13. Global Astragaloside III Sales by Manufacturers (2020-2025) & (kg)
Table 14. Global Astragaloside III Sales Share by Manufacturers (2020-2025)
Table 15. Global Astragaloside III Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Astragaloside III Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Astragaloside III by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Astragaloside III as of 2024)
Table 19. Global Astragaloside III Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Astragaloside III Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/g)
Table 21. Key Manufacturers Astragaloside III Manufacturing Base and Headquarters
Table 22. Global Astragaloside III Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Astragaloside III Sales by Type (2020-2025) & (kg)
Table 26. Global Astragaloside III Sales by Type (2026-2031) & (kg)
Table 27. Global Astragaloside III Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Astragaloside III Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Astragaloside III ASP by Type (2020-2031) & (US$/g)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Astragaloside III Sales by Application (2020-2025) & (kg)
Table 32. Global Astragaloside III Sales by Application (2026-2031) & (kg)
Table 33. Astragaloside III High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Astragaloside III Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Astragaloside III Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Astragaloside III ASP by Application (2020-2031) & (US$/g)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Astragaloside III Growth Accelerators and Market Barriers
Table 40. North America Astragaloside III Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Astragaloside III Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Astragaloside III Growth Accelerators and Market Barriers
Table 43. Europe Astragaloside III Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Astragaloside III Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Astragaloside III Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Astragaloside III Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Astragaloside III Growth Accelerators and Market Barriers
Table 48. Southeast Asia Astragaloside III Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Astragaloside III Investment Opportunities and Key Challenges
Table 50. Central and South America Astragaloside III Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Astragaloside III Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Astragaloside III Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. MedChemExpresss Corporation Information
Table 54. MedChemExpresss Description and Major Businesses
Table 55. MedChemExpresss Product Models, Descriptions and Specifications
Table 56. MedChemExpresss Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 57. MedChemExpresss Sales Value Proportion by Product in 2024
Table 58. MedChemExpresss Sales Value Proportion by Application in 2024
Table 59. MedChemExpresss Sales Value Proportion by Geographic Area in 2024
Table 60. MedChemExpresss Astragaloside III SWOT Analysis
Table 61. MedChemExpresss Recent Developments
Table 62. Merck Corporation Information
Table 63. Merck Description and Major Businesses
Table 64. Merck Product Models, Descriptions and Specifications
Table 65. Merck Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 66. Merck Sales Value Proportion by Product in 2024
Table 67. Merck Sales Value Proportion by Application in 2024
Table 68. Merck Sales Value Proportion by Geographic Area in 2024
Table 69. Merck Astragaloside III SWOT Analysis
Table 70. Merck Recent Developments
Table 71. RayBiotech Corporation Information
Table 72. RayBiotech Description and Major Businesses
Table 73. RayBiotech Product Models, Descriptions and Specifications
Table 74. RayBiotech Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 75. RayBiotech Sales Value Proportion by Product in 2024
Table 76. RayBiotech Sales Value Proportion by Application in 2024
Table 77. RayBiotech Sales Value Proportion by Geographic Area in 2024
Table 78. RayBiotech Astragaloside III SWOT Analysis
Table 79. RayBiotech Recent Developments
Table 80. ChromaDex Corporation Information
Table 81. ChromaDex Description and Major Businesses
Table 82. ChromaDex Product Models, Descriptions and Specifications
Table 83. ChromaDex Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 84. ChromaDex Sales Value Proportion by Product in 2024
Table 85. ChromaDex Sales Value Proportion by Application in 2024
Table 86. ChromaDex Sales Value Proportion by Geographic Area in 2024
Table 87. ChromaDex Astragaloside III SWOT Analysis
Table 88. ChromaDex Recent Developments
Table 89. BOC Sciences Corporation Information
Table 90. BOC Sciences Description and Major Businesses
Table 91. BOC Sciences Product Models, Descriptions and Specifications
Table 92. BOC Sciences Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 93. BOC Sciences Sales Value Proportion by Product in 2024
Table 94. BOC Sciences Sales Value Proportion by Application in 2024
Table 95. BOC Sciences Sales Value Proportion by Geographic Area in 2024
Table 96. BOC Sciences Astragaloside III SWOT Analysis
Table 97. BOC Sciences Recent Developments
Table 98. ChemFaces Corporation Information
Table 99. ChemFaces Description and Major Businesses
Table 100. ChemFaces Product Models, Descriptions and Specifications
Table 101. ChemFaces Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 102. ChemFaces Recent Developments
Table 103. Adooq Bioscience Corporation Information
Table 104. Adooq Bioscience Description and Major Businesses
Table 105. Adooq Bioscience Product Models, Descriptions and Specifications
Table 106. Adooq Bioscience Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 107. Adooq Bioscience Recent Developments
Table 108. Key Organics Corporation Information
Table 109. Key Organics Description and Major Businesses
Table 110. Key Organics Product Models, Descriptions and Specifications
Table 111. Key Organics Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 112. Key Organics Recent Developments
Table 113. TargetMol Corporation Information
Table 114. TargetMol Description and Major Businesses
Table 115. TargetMol Product Models, Descriptions and Specifications
Table 116. TargetMol Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 117. TargetMol Recent Developments
Table 118. Meilunbio Corporation Information
Table 119. Meilunbio Description and Major Businesses
Table 120. Meilunbio Product Models, Descriptions and Specifications
Table 121. Meilunbio Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 122. Meilunbio Recent Developments
Table 123. Herbest Corporation Information
Table 124. Herbest Description and Major Businesses
Table 125. Herbest Product Models, Descriptions and Specifications
Table 126. Herbest Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 127. Herbest Recent Developments
Table 128. Key Raw Materials Distribution
Table 129. Raw Materials Key Suppliers
Table 130. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 131. Milestones in Production Technology Evolution
Table 132. Distributors List
Table 133. Market Trends and Market Evolution
Table 134. Market Drivers and Opportunities
Table 135. Market Challenges, Risks, and Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Astragaloside III Product Picture
Figure 2. Global Astragaloside III Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Purity≥98% Product Picture
Figure 4. Purity ≥95% Product Picture
Figure 5. Others Product Picture
Figure 6. Global Astragaloside III Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Medical
Figure 8. Scientific Research
Figure 9. Others
Figure 10. Astragaloside III Report Years Considered
Figure 11. Global Astragaloside III Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 13. Global Astragaloside III Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Astragaloside III Revenue Market Share by Region (2020-2031)
Figure 15. Global Astragaloside III Sales (2020-2031) & (kg)
Figure 16. Global Astragaloside III Sales (CAGR) by Region (2020-2031) (kg)
Figure 17. Global Astragaloside III Sales Market Share by Region (2020-2031)
Figure 18. Global Astragaloside III Capacity, Production and Utilization (2020-2031) & (kg)
Figure 19. Global Astragaloside III Production Trend by Region (2020-2031) (kg)
Figure 20. Global Astragaloside III Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. Astragaloside III Production Growth Rate in North America (2020-2031) & (kg)
Figure 23. Astragaloside III Production Growth Rate in Europe (2020-2031) & (kg)
Figure 24. Astragaloside III Production Growth Rate in China (2020-2031) & (kg)
Figure 25. Astragaloside III Production Growth Rate in Japan (2020-2031) & (kg)
Figure 26. Top 5 and Top 10 Manufacturers Astragaloside III Sales Volume Market Share in 2024
Figure 27. Global Astragaloside III Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. Purity≥98% Revenue Market Share by Manufacturer in 2024
Figure 30. Purity ≥95% Revenue Market Share by Manufacturer in 2024
Figure 31. Others Revenue Market Share by Manufacturer in 2024
Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 34. Global Astragaloside III Sales Market Share by Type (2020-2031)
Figure 35. Global Astragaloside III Revenue Market Share by Type (2020-2031)
Figure 36. Global Astragaloside III Sales Market Share by Application (2020-2031)
Figure 37. Global Astragaloside III Revenue Market Share by Application (2020-2031)
Figure 38. North America Astragaloside III Sales YoY (2020-2031) & (kg)
Figure 39. North America Astragaloside III Revenue YoY (2020-2031) & (US$ Million)
Figure 40. North America Top 5 Manufacturers Astragaloside III Sales Revenue (US$ Million) in 2024
Figure 41. North America Astragaloside III Sales Volume (kg) by Type (2020- 2031)
Figure 42. North America Astragaloside III Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 43. North America Astragaloside III Sales Volume (kg) by Application (2020-2031)
Figure 44. North America Astragaloside III Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. US Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 46. Canada Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 47. Mexico Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 48. Europe Astragaloside III Sales YoY (2020-2031) & (kg)
Figure 49. Europe Astragaloside III Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Europe Top 5 Manufacturers Astragaloside III Sales Revenue (US$ Million) in 2024
Figure 51. Europe Astragaloside III Sales Volume (kg) by Type (2020-2031)
Figure 52. Europe Astragaloside III Sales Revenue (US$ Million) by Type (2020-2031)
Figure 53. Europe Astragaloside III Sales Volume (kg) by Application (2020-2031)
Figure 54. Europe Astragaloside III Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Germany Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 56. France Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 57. U.K. Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 58. Italy Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 59. Russia Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Astragaloside III Sales YoY (2020-2031) & (kg)
Figure 61. Asia-Pacific Astragaloside III Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Top 8 Manufacturers Astragaloside III Sales Revenue (US$ Million) in 2024
Figure 63. Asia-Pacific Astragaloside III Sales Volume (kg) by Type (2020- 2031)
Figure 64. Asia-Pacific Astragaloside III Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 65. Asia-Pacific Astragaloside III Sales Volume (kg) by Application (2020-2031)
Figure 66. Asia-Pacific Astragaloside III Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Indonesia Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 68. Japan Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 69. South Korea Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 70. China Taiwan Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 71. India Astragaloside III Revenue (2020-2031) & (US$ Million)
Figure 72. Central and South America Astragaloside III Sales YoY (2020-2031) & (kg)
Figure 73. Central and South America Astragaloside III Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Central and South America Top 5 Manufacturers Astragaloside III Sales Revenue (US$ Million) in 2024
Figure 75. Central and South America Astragaloside III Sales Volume (kg) by Type (2021-2031)
Figure 76. Central and South America Astragaloside III Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Central and South America Astragaloside III Sales Volume (kg) by Application (2020-2031)
Figure 78. Central and South America Astragaloside III Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. Brazil Astragaloside III Revenue (2020-2025) & (US$ Million)
Figure 80. Argentina Astragaloside III Revenue (2020-2025) & (US$ Million)
Figure 81. Middle East, and Africa Astragaloside III Sales YoY (2020-2031) & (kg)
Figure 82. Middle East and Africa Astragaloside III Revenue YoY (2020-2031) & (US$ Million)
Figure 83. Middle East and Africa Top 5 Manufacturers Astragaloside III Sales Revenue (US$ Million) in 2024
Figure 84. Middle East and Africa Astragaloside III Sales Volume (kg) by Type (2021-2031)
Figure 85. South America Astragaloside III Sales Revenue (US$ Million) by Type (2020-2031)
Figure 86. Middle East and Africa Astragaloside III Sales Volume (kg) by Application (2020-2031)
Figure 87. Middle East and Africa Astragaloside III Sales Revenue (US$ Million) by Application (2020-2031)
Figure 88. GCC Countries Astragaloside III Revenue (2020-2025) & (US$ Million)
Figure 89. Turkey Astragaloside III Revenue (2020-2025) & (US$ Million)
Figure 90. Egypt Astragaloside III Revenue (2020-2025) & (US$ Million)
Figure 91. South Africa Astragaloside III Revenue (2020-2025) & (US$ Million)
Figure 92. Astragaloside III Industry Chain Mapping
Figure 93. Regional Astragaloside III Manufacturing Base Distribution (%)
Figure 94. Astragaloside III Production Process
Figure 95. Regional Astragaloside III Production Cost Structure
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
